⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Mahmoud Al MasryM.D

Neurology · Andover, MA 01810

NPI: 1851694889

Share:

35

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers95th percentile opioid prescribing

Risk indicators are statistical patterns, not allegations. Learn more

1,536

Total Claims

$89K

Drug Cost

425

Beneficiaries

$210

Cost/Patient

Risk Score Breakdown 35/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Opioid rate (national percentile)+10

Score components are additive. Read full methodology

Peer Comparison vs. 13,194 Neurology providers

+4226%

Opioid rate vs peers

56.6% vs 1.3% avg

-95%

Cost per patient vs peers

$210 vs $4,034 avg

-21%

Brand preference vs peers

7.4% vs 9.4% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 4,226% above the average for Neurology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

56.6%

Opioid Rate

869

Opioid Claims

$58K

Opioid Cost

17.8%

Long-Acting Rate

This provider's opioid prescribing rate of 56.6% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

93% generic

Brand: 114 claims · $52K

Generic: 1,422 claims · $38K

Patient Profile

66

Avg Age

56%

Female

1.78

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About